Retatrutide and Body Composition Detailed body composition data from the retatrutide Phase 2 trial has not been fully published
Attia, E
A., Herzke, D., Harju, M., Amundsen, P
Benefits may reverse if the medication is stopped, often leading to weight regain and blood sugar spikes meaning these are not short-term interventions for most people who take them
"We are pleased to see that our latest incretin medicine meets our expectations for safety and tolerability, glucose control and weight loss, and we look forward to additional data readouts later this year" Over 65 percent of participants given the highest orforglipron dose attained an A1C level less than or equal to 6.5 percent
As we age, the body is very slowly ramping us down over years and decades